Endothelin-1 is significantly elevated in plasma of patients with vitiligo treated with psoralen plus ultraviolet A

Clinical and Experimental Dermatology

Volumn 31, Issue 4, 2006, Pages 571-575

  Abdel Naser, M B ^a,b   El Khateeb, E A ^a   Sallam, T H ^a   Habib, M A ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b 4 Al Rahman Tower ^*  (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; METHOXSALEN;

ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; MELANOCYTE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PSORIASIS AREA SEVERITY INDEX; PSORIASIS SEVERITY INDEX; PUVA; SCORING SYSTEM; ULTRAVIOLET A RADIATION; VITILIGO; VITILIGO AREA SCORING INDEX;

ADULT; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MELANOCYTES; PSORIASIS; PUVA THERAPY; VITILIGO;

EID: 33744475352     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02148.x     Document Type: Article

References (25)

1. Parrish JA, Fitzpatrick TB, Shea C, Pathak MA. Photochemotherapy of vitiligo: use of orally administered psoralens and a high-intensity long-wave ultraviolet light system. Arch Dermatol 1976 112 : 1531 4.
2. Abdel-Naser MB, Krasagakis K, Garbe C, Eberle J. Direct effects on proliferation, antigen expression and melanin synthesis of cultured normal human melanocytes in response to UVB and UVA light. Photodermatol Photoimmunol Photomed 2003 19 : 122 7.
3. Abdel-Naser M, Hann SK, Bystryn JC. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation. Arch Dermatol 1997 133 : 1530 3.
4. Stern RS, Bagheri S, Nichols K. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J Am Acad Dermatol 2002 47 : 33 9.
5. Stierner U, Rosdahl I, Augustsson A, Kagedal B. UVB irradiation induces melanocyte increase in both exposed and shielded skin. J Invest Dermatol 1989 92 : 561 4.
6. Abdel-Naser MB, Wollina U, El-Okby M, El-Shiemy S. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin. Clin Exp Dermatol 2004 29 : 380 2.
7. Agarwal US, Gulati R, Shukla SR, Mathur N. Satellite repigmentation after punch grafting. Int J Dermatol 2004 43 : 273 4. Erratum in Int J Dermatol 2004; 43: 626.
8. Archambault M, Yaar M, Gilchrest BA. Keratinocyte and fibroblasts in human skin equivalent model enhance melanocyte survival and melanin synthesis after ultraviolet irradiation. J Invest Dermatol 1995 104 : 859 67.
9. Horikawa T, Norris DA, Yohn JJ et al. Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J Invest Dermatol 1995 104 : 256 9.
10. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 1992 267 : 24675 80.
11. Melski JW, Tanenbaum L, Parrish JA et al. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol 1977 68 : 328 35.
12. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978 157 : 238 44.
13. Hamzavi I, Jain H, McLean D et al. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol 2004 140 : 677 83.
14. Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004 17 : 96 110.
15. McLaren M, Kirk G, Bolton-Smith C, Belch JJ. Seasonal variation in plasma levels of endothelin-1 and nitric oxide. Int Angiol 2000 19 : 351 3.
16. Yildiz L, Akcay F, Aktas A et al. Increased concentrations of plasma endothelin-1 and fibronectin in psoriasis. Acta Derm Venereol 1997 77 : 166 7.
17. Bonifati C, Mussi A, Carducci M et al. Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venereol 1998 78 : 22 6.
18. Zachariae H, Heickendorff L, Bjerring P. Plasma endothelin in psoriasis. possible relations to therapy and toxicity. Acta Derm Venereol 1996 76 : 442 3.
19. Kruse HJ, Wieczorek I, Hecker H et al. Seasonal variation of endothelin-1, angiotensin II, and plasma catecholamines and their relation to outside temperature. J Lab Clin Med 2002 140 : 236 41.
20. Kanai H, Hirakata H, Nakayama M et al. Minimal daily variations of plasma and urinary endothelin-1 in healthy subjects. Clin Nephrol 1996 46 : 353 4.
21. Elherik K, Khan F, McLaren M et al. Circadian variation in vascular tone and endothelial cell function in normal males. Clin Sci (Lond) 2002 102 : 547 52.
22. Parker JD, Thiessen JJ, Reilly R et al. Human endothelin-1 clearance kinetics revealed by a radiotracer technique. J Pharmacol Exp Ther 1999 289 : 261.
23. Parker JD, Thiessen JJ. Increased endothelin-1 production in patients with chronic heart failure. Am J Physiol Heart Circ Physiol 2004 286 : H1141 5.
24. Bleehen S, Anstey A. Disorders of skin colour. Chapter 39. In : Rook's Textbook of Dermatology. Burns T, Breathnach S, Cox N, Griffiths C, eds), 7th edn. Malden, Mass : Blackwell Science, 2004.
25. Kadekaro AL, Kavanagh R, Kanto H et al. alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 2005 65 : 4292 9.